Oncolytics Biotech (ONCY) Price to Earnings (2009 - 2026)
Oncolytics Biotech's (ONCY) quarterly Price to Earnings came in at 12.54 in Q2 2026, up 27.66% year-over-year from 9.82 in Q2 2025, and little changed quarter-over-quarter from 12.59 in Q3 2025.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Price to Earnings (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Price to Earnings for 18 consecutive years, with 12.54 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Earnings rose 27.66% year-over-year to 12.54 in Q2 2026; TTM through Jun 2026 was 3.91, a 15.53% decrease from a year earlier, with the FY2025 full-year figure at 3.27, down 3.08% from the prior year.
- Price to Earnings was 12.54 for Q2 2026 at Oncolytics Biotech, roughly flat from 12.59 in the prior quarter.
- Over five years, Price to Earnings peaked at 9.28 in Q3 2024 and troughed at 35.41 in Q4 2023.
- A 5-year average of 17.34 and a median of 15.17 in 2022 frame the typical range for Price to Earnings.
- Across the five-year window, Price to Earnings slumped 177.75% in 2023 and surged 63.96% in 2024, its largest moves.
- Over 5 years, Price to Earnings stood at 16.08 in 2022, then tumbled by 120.24% to 35.41 in 2023, then surged by 63.96% to 12.76 in 2024, then gained by 1.33% to 12.59 in 2025, then gained by 0.41% to 12.54 in 2026.
- The last three Price to Earnings figures came in at 12.54 (Q2 2026), 12.59 (Q3 2025), and 17.34 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Oncolytics Biotech | 91.92 Mn | 91.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.54 |
| Sep 30, 2025 | -12.59 |
| Jun 30, 2025 | -17.34 |
| Dec 31, 2024 | -12.76 |
| Sep 30, 2024 | -9.28 |
| Jun 30, 2024 | -14.26 |
| Dec 31, 2023 | -35.41 |
| Sep 30, 2023 | -18.08 |
| Jun 30, 2023 | -29.15 |
| Dec 31, 2022 | -16.08 |
| Sep 30, 2022 | -20.05 |
| Jun 30, 2022 | -10.50 |
| Dec 31, 2021 | -12.58 |
| Sep 30, 2021 | -25.00 |
| Jun 30, 2021 | -21.69 |
| Dec 31, 2020 | -15.36 |
| Sep 30, 2020 | -7.39 |
| Jun 30, 2020 | -8.45 |
| Mar 31, 2020 | 76.44 |
| Sep 30, 2019 | -2.81 |